US EditionFTC eyes trans youth care providers, seeking input on alleged deceptive practices investigation
UNITED STATES, JUL 28 – The Federal Trade Commission seeks public input on misleading claims about gender-affirming care for minors to assess potential consumer harm and regulatory violations.
- On Monday, the Federal Trade Commission launched a public inquiry to understand exposure to false claims about `gender-affirming care`, with comments due by Sept. 26.
- Amid the Trump administration's campaign against transgender care for minors, the FTC held a workshop earlier this month on `gender-affirming` care amid rising scrutiny.
- The FTC seeks to evaluate whether medical professionals may have violated Sections 5 and 12 of the FTC Act by failing to disclose material risks related to `gender-affirming care`.
- Beginning last week, Children's National Hospital said it will discontinue prescribing gender-affirming medications effective Aug. 30.
- The administration's stance follows a release from HHS, stating medical ethics should be central in the debate over `gender-affirming care` after President Donald Trump's January executive order.
15 Articles
15 Articles
The Federal Trade Commission (FTC) announced on Monday a public investigation to assess whether health care providers claiming gender are violating federal consumer protection laws, with a particular focus on child care. Read more]]>
FTC eyes trans youth care providers, seeking input on alleged deceptive practices investigation
The Federal Trade Commission (FTC) on Monday launched a public inquiry into whether providers of gender-affirming health care are violating federal consumer protection laws. In a news release, the FTC said it opened the inquiry “to better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care’, especially as it relates…
FTC Opens Public Inquiry Into ‘Gender-Affirming’ Care Claims
The Federal Trade Commission (FTC) said on July 28 that it has launched a public inquiry into whether consumers, particularly minors, have been harmed by false or unsubstantiated claims about “gender-affirming care,” and whether such practices may violate federal law. The launch of the public inquiry follows a July 9 FTC workshop that featured testimony from doctors, ethicists, whistleblowers, detransitioners, and parents who alleged that some p…
Trump admin scrutinizes whether health providers disclose transgender treatment risks
President Donald Trump's administration began investigating whether healthcare providers are misrepresenting or failing to disclose the risks of transgender procedures and care this week.The Federal Trade Commission announced the investigation on Monday, giving consumers a window through September 26 to come forward with any concerns that they may have been "exposed to false or unsupported claims about ‘gender-affirming care,’ especially as it r…
Coverage Details
Bias Distribution
- 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
